Pan Tong

2.2k total citations
21 papers, 545 citations indexed

About

Pan Tong is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Pan Tong has authored 21 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Pan Tong's work include Lung Cancer Research Studies (7 papers), Gene expression and cancer classification (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Pan Tong is often cited by papers focused on Lung Cancer Research Studies (7 papers), Gene expression and cancer classification (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Pan Tong collaborates with scholars based in United States, China and Taiwan. Pan Tong's co-authors include Jing Wang, Lauren A. Byers, John V. Heymach, Triparna Sen, Lerong Li, Lixia Diao, C. Allison Stewart, Bonnie S. Glisson, You-Hong Fan and Meihong Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and PLoS ONE.

In The Last Decade

Pan Tong

20 papers receiving 541 citations

Peers

Countries citing papers authored by Pan Tong

Since Specialization

Citations

This map shows the geographic impact of Pan Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Tong more than expected).

Fields of papers citing papers by Pan Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Tong. The network helps show where Pan Tong may publish in the future.

Co-authorship network of co-authors of Pan Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Tong. A scholar is included among the top collaborators of Pan Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Tong. Pan Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coenzyme Q10 ameliorates obesity by promoting white adipose tissue browning and preserving mitochondrial dynamics in ovariectomized rats fed a high-fat diet 2025 ·The Journal of Nutritional Biochemistry ·Pan Tong, Shuying Chen, (unknown), Chien‐Jen Chen, Pao‐Yun Cheng, Hsin‐Hsueh Shen, (unknown), Yen‐Mei Lee	0
2	Xiaobugan decoction prevents CCl4-induced acute liver injury by modulating gut microbiota and hepatic metabolism 2024 ·Phytomedicine ·Weiwei Zheng, (unknown), Chao Shi, (unknown), (unknown), Pan Tong, (unknown), Qiuhong Xie, Hongyu Xiang	4
3	Inhibitory effects of naringenin on estrogen deficiency-induced obesity via regulation of mitochondrial dynamics and AMPK activation associated with white adipose tissue browning 2024 ·Life Sciences ·Pan Tong, Yen‐Mei Lee, Eiki Takimoto, Kazutaka Ueda, Pang‐Yen Liu, Hsin‐Hsueh Shen	10
4	Integrated network analysis and metabolomics reveal the molecular mechanism of Yinchen Sini decoction in CCl4-induced acute liver injury 2023 ·Frontiers in Pharmacology ·Weiwei Zheng, Chao Shi, (unknown), Jian Peng, (unknown), Pan Tong, (unknown), Qiuhong Xie, Hongyu Xiang	7
5	Christensenella regulated by Huang-Qi-Ling-Hua-San is a key factor by which to improve type 2 diabetes 2022 ·Frontiers in Microbiology ·Pan Tong, (unknown), Weiwei Zheng, Chao Shi, Ke Ning, Qinghui Zhang, (unknown), (unknown), Qiuhong Xie	21
6	Genomic and transcriptomic landscape of oral pre-cancers (OPCs) and risk of oral cancer (OC). 2019 ·Journal of Clinical Oncology ·William Nassib William, Won‐Chul Lee, J. Jack Lee, Heather Lin, Agda Karina Eterovic, Adel K. El‐Naggar, Ann M. Gillenwater, Marlese A. Pisegna, Pan Tong, Lerong Li, (unknown), Hai T. Tran, Pierre Saintigny, Jing Wang, Vassiliki A. Papadimitrakopoulou, Scott M. Lippman, Phillip Andrew Futreal, John V. Heymach, Jianjun Zhang	11
7	Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers 2018 ·Clinical Cancer Research ·Carl M. Gay, Pan Tong, Robert J. Cardnell, Triparna Sen, (unknown), Jun Ma, (unknown), Faye M. Johnson, Chris Wakefield, John V. Heymach, Jing Wang, Lauren A. Byers	12
8	Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants 2018 ·Cancer Letters ·Nene N. Kalu, Tuhina Mazumdar, Shaohua Peng, Pan Tong, Li Shen, Jing Wang, Upasana Banerjee, Jeffrey N. Myers, Curtis R. Pickering, David Brunell, Clifford Stephan, Faye M. Johnson	21
9	Abstract 2822: ATR inhibitors are active as single agents and in combination with PARP1 and ATM inhibitors in molecularly distinct subsets of small cell lung cancer models 2018 ·Cancer Research ·Carl M. Gay, Pan Tong, Lerong Li, C. Allison Stewart, Triparna Sen, Bonnie S. Glisson, John V. Heymach, Jing Wang, Lauren A. Byers	3
10	Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer 2017 ·Clinical Cancer Research ·Triparna Sen, Pan Tong, Lixia Diao, Lerong Li, You-Hong Fan, (unknown), John V. Heymach, Jing Wang, Lauren A. Byers	101
11	iTRAQ‐Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha‐1‐Antitrypsin as Potential Biomarkers 2017 ·Evidence-based Complementary and Alternative Medicine ·Y YANG, (unknown), (unknown), Mingjun Wu, Zhenbing Lv, Pan Tong, Rui Chang	8
12	The role of hepatocyte nuclear factor 1 homeobox B (HNF1B) loss in chromophobe RCC (ChRCC) development 2017 ·Annals of Oncology ·Eric Jonasch, Gregory N. Fuller, Ian E. McCutcheon, Zhenfeng Ding, Lanlan Zhou, X Liu, Wen Kong, Reid T. Powell, (unknown), Nizar M. Tannir, W. Kimryn Rathmell, Baijun Dong, Surena F. Matin, Xiaowen Tong, Yiran Huang, Pan Tong, (unknown), Cheryl L. Walker, Mianen Sun	2
13	CAsubtype: An R Package to Identify Gene Sets Predictive of Cancer Subtypes and Clinical Outcomes 2017 ·Interdisciplinary Sciences Computational Life Sciences ·(unknown), Pan Tong, Xiaodong Zhao, Jielin Sun, Hua Li	5
14	CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib 2017 ·Cancer Research ·Triparna Sen, Pan Tong, C. Allison Stewart, Sandra Cristea, Aly Valliani, David S. Shames, Abena B. Redwood, You Hong Fan, Lerong Li, Bonnie S. Glisson, John D. Minna, Julien Sage, Don L. Gibbons, Helen Piwnica‐Worms, John V. Heymach, Jing Wang, Lauren A. Byers	145
15	Anti‐inflammatory and anti‐arthritic properties of naringenin via attenuation of NF‐κB and activation of the heme oxygenase ﴾HO﴿‐1/related factor 2 pathway 2017 ·Pharmacological Reports ·Rong Fan, Pan Tong, (unknown), Meihong Zhang	41
16	Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies 2017 ·Oncotarget ·Robert J. Cardnell, Lerong Li, Triparna Sen, (unknown), Pan Tong, Junya Fujimoto, Abbie S. Ireland, Matthew R. Guthrie, Sheila Bheddah, Upasana Banerjee, Nene N. Kalu, You-Hong Fan, Scott J. Dylla, Faye M. Johnson, Ignacio I. Wistuba, Trudy G. Oliver, John V. Heymach, Bonnie S. Glisson, Jing Wang, Lauren A. Byers	61
17	Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer 2016 ·PLoS ONE ·Robert J. Cardnell, Ying Feng, (unknown), Lixia Diao, Pan Tong, C. Allison Stewart, Fatemeh Masrorpour, You-Hong Fan, Monique B. Nilsson, Yuqiao Shen, John V. Heymach, Jing Wang, Lauren A. Byers	65
18	Abstract LB-132: Proteomic profiling identifies ATM expression level as a predictive biomarker to ATR and PARP inhibition in small cell lung cancer (SCLC) 2016 ·Cancer Research ·Triparna Sen, Pan Tong, Jing Wang, Lauren A. Byers	4
19	SIBER: systematic identification of bimodally expressed genes using RNAseq data 2013 ·Bioinformatics ·Pan Tong, Yong Chen, Xiao Su, Kevin R. Coombes	20
20	integIRTy: a method to identify genes altered in cancer by accounting for multiple mechanisms of regulation using item response theory 2012 ·Bioinformatics ·Pan Tong, Kevin R. Coombes	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact